GB0212622D0 - Bacterial transforming agent - Google Patents

Bacterial transforming agent

Info

Publication number
GB0212622D0
GB0212622D0 GBGB0212622.5A GB0212622A GB0212622D0 GB 0212622 D0 GB0212622 D0 GB 0212622D0 GB 0212622 A GB0212622 A GB 0212622A GB 0212622 D0 GB0212622 D0 GB 0212622D0
Authority
GB
United Kingdom
Prior art keywords
bacterial
transforming agent
transforming
agent
bacterial transforming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0212622.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATURAL TECHNOLOGIES GROUP Ltd
Original Assignee
NATURAL TECHNOLOGIES GROUP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATURAL TECHNOLOGIES GROUP Ltd filed Critical NATURAL TECHNOLOGIES GROUP Ltd
Priority to GBGB0212622.5A priority Critical patent/GB0212622D0/en
Publication of GB0212622D0 publication Critical patent/GB0212622D0/en
Priority to EP03756069A priority patent/EP1553981A1/en
Priority to IL16543303A priority patent/IL165433A0/xx
Priority to US10/517,359 priority patent/US20060040871A1/en
Priority to PCT/GB2003/002402 priority patent/WO2003101488A1/en
Priority to MXPA04011879A priority patent/MXPA04011879A/es
Priority to BR0311482-1A priority patent/BR0311482A/pt
Priority to JP2004508843A priority patent/JP2006504404A/ja
Priority to CA002487597A priority patent/CA2487597A1/en
Priority to NZ537447A priority patent/NZ537447A/en
Priority to AU2003232352A priority patent/AU2003232352A1/en
Priority to EA200401589A priority patent/EA007093B1/ru
Priority to NO20045680A priority patent/NO20045680L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0212622.5A 2002-05-31 2002-05-31 Bacterial transforming agent Ceased GB0212622D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0212622.5A GB0212622D0 (en) 2002-05-31 2002-05-31 Bacterial transforming agent
EA200401589A EA007093B1 (ru) 2002-05-31 2003-06-02 Средство для превращения бактерий
BR0311482-1A BR0311482A (pt) 2002-05-31 2003-06-02 Agente de transformação bacteriana
IL16543303A IL165433A0 (en) 2002-05-31 2003-06-02 Bacterial transforming agent
US10/517,359 US20060040871A1 (en) 2002-05-31 2003-06-02 Bacterial transforming agent
PCT/GB2003/002402 WO2003101488A1 (en) 2002-05-31 2003-06-02 Bacterial transforming agent
MXPA04011879A MXPA04011879A (es) 2002-05-31 2003-06-02 Agente transformante de bacterias.
EP03756069A EP1553981A1 (en) 2002-05-31 2003-06-02 Bacterial transforming agent
JP2004508843A JP2006504404A (ja) 2002-05-31 2003-06-02 細菌の形質転換剤
CA002487597A CA2487597A1 (en) 2002-05-31 2003-06-02 Bacterial transforming agent
NZ537447A NZ537447A (en) 2002-05-31 2003-06-02 Bacterial transforming agent
AU2003232352A AU2003232352A1 (en) 2002-05-31 2003-06-02 Bacterial transforming agent
NO20045680A NO20045680L (no) 2002-05-31 2004-12-28 Bakterietransformerende middel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0212622.5A GB0212622D0 (en) 2002-05-31 2002-05-31 Bacterial transforming agent

Publications (1)

Publication Number Publication Date
GB0212622D0 true GB0212622D0 (en) 2002-07-10

Family

ID=9937806

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0212622.5A Ceased GB0212622D0 (en) 2002-05-31 2002-05-31 Bacterial transforming agent

Country Status (13)

Country Link
US (1) US20060040871A1 (https=)
EP (1) EP1553981A1 (https=)
JP (1) JP2006504404A (https=)
AU (1) AU2003232352A1 (https=)
BR (1) BR0311482A (https=)
CA (1) CA2487597A1 (https=)
EA (1) EA007093B1 (https=)
GB (1) GB0212622D0 (https=)
IL (1) IL165433A0 (https=)
MX (1) MXPA04011879A (https=)
NO (1) NO20045680L (https=)
NZ (1) NZ537447A (https=)
WO (1) WO2003101488A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009036121A1 (en) * 2007-09-12 2009-03-19 Targanta Therapeutics Corp. Method of inhibiting clostridium difficile by administration of oritavancin
AU2010313228B2 (en) * 2009-10-30 2014-05-29 Biogenic Innovations, Llc Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
DE102010013587A1 (de) * 2010-03-31 2011-10-06 Heliolux Gmbh N-(Aminoacyl)-Amino-Ester
WO2012106469A2 (en) * 2011-02-01 2012-08-09 New York University Methods for treating infections by targeting microbial h2s-producing enzymes
HRP20200101T1 (hr) 2014-11-06 2020-04-03 Xellia Pharmaceuticals Aps Glikopeptidni pripravci
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
WO2018237268A1 (en) * 2017-06-22 2018-12-27 Brown University Novel antibacterial compounds and methods of making and using same
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
US6569830B1 (en) * 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains

Also Published As

Publication number Publication date
US20060040871A1 (en) 2006-02-23
NO20045680L (no) 2005-02-28
BR0311482A (pt) 2005-03-15
EA007093B1 (ru) 2006-06-30
JP2006504404A (ja) 2006-02-09
EA200401589A1 (ru) 2005-06-30
CA2487597A1 (en) 2003-12-11
MXPA04011879A (es) 2005-09-12
IL165433A0 (en) 2006-01-15
EP1553981A1 (en) 2005-07-20
WO2003101488A1 (en) 2003-12-11
NZ537447A (en) 2006-12-22
AU2003232352A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
DE50311874D1 (en) Spirocyclische cyclohexan-derivate
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
DE50309217D1 (en) Benzimidazolderivate
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
DE50303619D1 (en) Reibschweissvorrichtung
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
DE50307787D1 (en) Isophthalsäurederivate
DE50311133D1 (en) Carbonsäureamide
AU2003264900A8 (en) Cast-cutter
DE50310169D1 (en) Lingual-retainer
DE50304964D1 (en) Handhobelmaschine
AU2003206730A1 (en) Fitting
GB0212622D0 (en) Bacterial transforming agent
GB2382209B (en) Meeting aid
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003207181A1 (en) Microorganism-trapping agent
AU2003262681A8 (en) Hemo-aide
DE10392833D2 (en) Geotextilie
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
DE50309021D1 (en) Etherlacton
HK1078489A (en) Bacterial transforming agent
AU2002100956A4 (en) Curved Skatedeck

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)